• Thioguanine in EV71 Research: Assay-to-Mechanism

  2026-08-09

  Thioguanine, also known as 6-thioguanine, is examined here through an assay-to-mechanism framework centered on EV71 replication, BIRC3-mediated autophagy, and translational controls. Learn how to distinguish antiviral activity from cytotoxicity while connecting purine metabolism, epigenetic biology, and practical compound handling.

• Ceftolozane-Tazobactam in Nosocomial Pneumonia

  2026-08-08

  The reference paper explains how ceftolozane-tazobactam combines a structurally optimized cephalosporin with beta-lactamase inhibition to address difficult Gram-negative pneumonia, particularly infections caused by Pseudomonas aeruginosa. Its synthesis of molecular, microbiological, pharmacokinetic/pharmacodynamic, and ASPECT-NP data supports targeted use in hospital-acquired and ventilator-associated pneumonia while highlighting important limits in resistance coverage and clinical interpretation.

• In Vitro Drug Response: Viability Versus Cell Death

  2026-08-07

  Hannah R. Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of anticancer drug response. Its central contribution is a framework for separating growth inhibition from cell killing and interpreting their different proportions and time courses in vitro.

• Ampicillin Sodium: Optimizing β-Lactam Antibiotic Assays

  2026-08-07

  Ampicillin sodium’s robust β-lactam mechanism enables high-fidelity selection and antibacterial activity assays in both recombinant protein work and infection models. This guide translates reference-driven workflows and troubleshooting strategies into actionable protocols, maximizing reproducibility for antibiotic resistance and cell wall biosynthesis research.

• URB597 (KDS-4103): Selective FAAH Inhibitor for Neuroplastic

  2026-08-06

  URB597 (KDS-4103) is a highly selective FAAH inhibitor that elevates brain anandamide levels, with rapid in vivo onset and minimal off-target effects. APExBIO provides this reagent for reproducible endocannabinoid signaling and neuroplasticity studies. This dossier details its mechanism, benchmarks, and workflow integration for advanced pain and neuroinflammation research.

• Next-Gen Immunodetection: Rethinking HRP-Conjugated Secondar

  2026-08-06

  Unlocking the full potential of Affinity-Purified Goat Anti-Mouse IgG (H+L), HRP conjugated secondary antibodies, this article bridges mechanistic insight and strategic guidance for translational researchers. It frames signal amplification not merely as a technical feature, but as a driver of biological discovery—especially in the era of engineered neural circuits and clinical translation. By referencing cutting-edge DREADD research and dissecting the competitive landscape, we provide a blueprint for integrating robust secondary antibody protocols into next-generation workflows. This thought-leadership piece goes beyond standard guides, emphasizing practical, evidence-based parameters and the translational stakes of assay optimization.

• Treponema pallidum Triggers Hepatocyte Apoptosis via Mitocho

  2026-08-05

  This study elucidates how Treponema pallidum induces intrinsic apoptosis in hepatocytes through mitochondrial dysfunction, ROS accumulation, and cardiolipin peroxidation. The findings clarify the mechanistic link between bacterial infection and liver cell death, offering new perspectives for research on syphilitic liver pathology.

• Rapid Microwave Heating Preserves Lactoferrin Structure and

  2026-08-05

  This study demonstrates that rapid microwave (MW) heating, rather than dielectric effects, is the primary factor preserving lactoferrin's (LF) structural integrity and bioactivity during thermal processing. The findings guide improvements in industrial dairy pasteurization to maintain LF's immunomodulatory and anti-apoptotic functions.

• Self-Adaptive Nanocarriers and ROS-Responsive Chemotherapy i

  2026-08-04

  This study presents a dual-sensitive nanocarrier (DATCPT) engineered to overcome key physiological barriers in orthotopic pancreatic cancer by leveraging pH and reactive oxygen species (ROS) responsiveness. The findings demonstrate improved drug delivery, deep tumor penetration, and inhibition of metastasis, providing mechanistic insights into the tumor microenvironment and suggesting new strategies for nanomedicine development.

• SM-102: Structural Insights and Predictive Modeling in mRNA

  2026-08-04

  Delve into the molecular structure and predictive modeling of SM-102, a leading mRNA delivery lipid. This article uniquely examines the intersection of machine learning and ionizable lipid design, providing translational guidance for vaccine and therapeutic developers.

• AICAR phosphate (Acadesine): Reliable AMPK Activation Strate

  2026-08-03

  This article provides a scenario-driven guide for biomedical researchers and lab technicians working with apoptosis, cell viability, and cytotoxicity assays. It highlights how 'AICAR phosphate (Acadesine)' (SKU B1211) from APExBIO delivers reproducible, high-purity AMPK activation and B-CLL-selective apoptosis, supporting evidence-based workflow optimization.

• Mithramycin A: Applied Protocols Advancing Cancer Biology Re

  2026-08-03

  Mithramycin A empowers researchers to dissect oncogenic transcriptional networks and cellular differentiation, especially in leukemia and cardiac injury models. This guide delivers actionable workflows, protocol refinements, and troubleshooting strategies to maximize the impact of this anticancer antibiotic in advanced experimental settings.

• Structural Insights into CD38 CAR Binders Guide Affinity Tun

  2026-08-02

  This study dissects how two distinct CAR binders recognize and inhibit the CD38 antigen, a major target for hematologic malignancies. By resolving their structural interactions and linking them to functional outcomes, the research offers a blueprint for optimizing CAR-T specificity and safety through rational affinity tuning.

• NMDA (N-Methyl-D-aspartic acid): Precision Control in CNS Ex

  2026-08-01

  Explore the unique capabilities of NMDA (N-Methyl-D-aspartic acid) as a selective agonist for advanced excitotoxicity and neurodegeneration research. This article highlights technical nuances, new mechanistic insights, and best practices for reproducible CNS modeling.

• Fucoidan: Mechanistic Insights and Strategic Targets in Brea

  2026-07-31

  Explore the multifaceted mechanisms of Fucoidan, a sulfated α-L-Fucan, in breast cancer therapy. This in-depth analysis reveals novel pathways, translational considerations, and practical assay insights for researchers seeking truly differentiated perspectives.

444 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page